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The Complexity Involved in




About the size of the average cigarette butt, the left main
coronary artery is a relatively small vessel, yet it is arguably
1 of the most valuable sections of real estate within the
body. Since Herrick’s description 100 years ago, we are well
aware of the lethality of left main disease (1). Stenosis of the
left main coronary is 1 of the few, specific coronary lesions
in which revascularization reduces the likelihood of death
compared with medical therapy (2–4). Thus, seeking out
and revascularizing left main disease has become established
as 1 of the tenets of modern cardiology.
See page 1021
Identification of significant left main disease is not always
easy. Angiography routinely underestimates and overesti-
mates the degree of left main narrowing. This is particularly
true for ostial, distal bifurcation, and diffusely diseased
segments or in the presence of dense calcium or eccentric
isease (Fig. 1). Wary of missing a potentially lethal condi-
ion, clinicians tend to “overcall” lesions and refer patients
or bypass surgery who might not actually have significant
tenosis. When this happens, grafts may occlude or become
tretic (5). Thus, there are consequences to both missing the
iagnosis as well as overestimating disease severity. It is
eally important to get this right.
Adjunctive methods, including fractional flow reserve
FFR) and intravascular ultrasound (IVUS), have been
mployed in the assessment of ambiguous left main lesions
6–12). For IVUS, minimal luminal area (MLA) is mea-
ured; the cutoff value defining significance is not entirely
lear. The lower range for a normal left main stem is 7.5
m2 (6). An MLA 5.9 mm2 has been shown to correlate
ith an ischemic FFR in 1 study (7), but in another study,
n MLA 4.8 mm2 best predicted FFR 0.80 (8). It
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xceeds 6.0 mm2 or if FFR is greater than 0.80 (7–12).
There are important considerations when performing
FFR of an ambiguous left main lesion. Ostial disease may
dampen the catheter pressure and falsely raise FFR. There-
fore, it is recommended that the operator disengage the
guide catheter after the pressure wire is positioned distal to
the stenosis and use intravenous rather than intracoronary
adenosine (13). In addition, the presence of disease in other
vessels may affect the measurement of FFR. This is espe-
cially important because isolated left main disease is actually
quite rare. In an unselected series of patients undergoing
coronary angiography, isolated left main disease was present
in only 9%; 17% had left main plus 1-vessel disease, 35%
had left main plus 2-vessel disease, and 38% had left main
plus 3-vessel disease (14). In the SYNTAX (Synergy Be-
tween Percutaneous Coronary Intervention With Taxus and
Cardiac Surgery) trial, isolated left main disease was ob-
served in only 6.1% of patients (15). Thus, we expect to find
significant coronary disease in other vessels in more than
90% of patients with left main disease. This creates a
challenge because if there is disease in both the left main
and the left anterior descending artery (LAD), the operator
cannot simply position the pressure sensor across just the
left main lesion into the LAD and measure FFR. The LAD
stenosis may hamper maximal hyperemia and falsely raise
the FFR (13). Complex methodology to measure the FFR
of each lesion in series has been described but is not practical
for clinical use (16,17). Therefore, if there is disease in the
left circumflex artery (LCX) or LAD, FFR of the left main
is performed by positioning the transducer across the left
main lesion into the uninvolved artery. But is this method-
ology sound? It is plausible that a stenosis in either vessel
might still impair total flow across the left main. How does
a proximal stenosis in the LCX or LAD influence the
accuracy of FFR measurement when the pressure transducer
is placed in the uninvolved artery?
This question was elegantly addressed by Daniels et al.
(18) in this issue of JACC: Cardiovascular Interventions.
Using an in vitro, experimental model of the coronary
circulation, they first determined the “true FFR” of the left
main segment in the absence of a downstream stenosis and
then remeasured FFR (“FFR apparent”) in the presence of
variable degrees of stenosis in the LAD or the LCX with
the sensor in the uninvolved artery. They found that, in the
presence of mild to moderate disease in the LAD or LCX,
the FFR across the left main did not differ from the true
FFR. However, in the presence of significant disease in the
LAD or LCX (which they arbitrarily defined as a com-
posite FFR 0.65), FFR across the left main was higher
than the true FFR. This was particularly evident for lesions in the
LAD compared with disease in the LCX.
How should this study affect practice? Although this
work was not performed or subsequently validated in hu-
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1027mans, the clinical implications are clear. If there is mild or
moderate disease in the LAD or LCX, then FFR of an
ambiguous left main can be performed with the wire
positioned in the uninvolved artery. If there is concern about
the severity of disease in the LAD or LCX, a composite
FFR can be performed with the wire placed across both
lesions; if this composite FFR is0.65, then FFR of the left
main with the wire repositioned into the uninvolved artery
will be reliable. However, if the composite FFR is 0.65,
then the left main should be assessed by IVUS using the
cutoff value for MLA of 6.0 mm2.
Obviously, verification of these results in humans with
left main disease will be interesting and important but will
Figure 1. Example of an Ambiguous Left Main Lesion Involving the Ostium
In this case, the ostium of the left main appeared normal in some views
but narrowed signiﬁcantly in the right anterior oblique cranial view (A).
Intravascular ultrasound noted an eccentric and elliptical lumen with a
minimal luminal area of 10.10 mm2 (B).prove difficult to accomplish. Unlike the experimentalmodel used by Daniels et al. (18), the variable location,
extent, and severity of coexisting disease cannot be con-
trolled. It is possible that a small cohort in whom FFR of
the left main is performed before and after treatment of a
stenosis in the LAD or LCX can be studied to provide some
validation of these findings, but these patients will be
difficult to find and enroll.
This study raises additional questions. How might FFR
of the left main be influenced by occlusive disease in a large
right coronary? One might theorize that collaterals emanat-
ing from the left will, in effect, increase the size of the
vascular bed of the left main and result in greater flow than
normal, potentially falsely lowering the FFR and perhaps
misleading the operator to conclude that the left main is
significant when it may not be in the absence of an occluded
right coronary. Similarly, this study did not take into
account collateral dependence to the LCX or LAD in the
event of occlusive disease in these vessels nor did it address
the impact of disease in large branches of these vessels.
It is clearly important for clinicians to understand the
message provided by this study and to recognize the
complexity involved in assessment of a left main lesion. As
we increase our understanding of these nuances, we will be
more likely to “get it right” and make the correct decisions
for patients with disease in this small but crucial segment of
the coronary circulation.
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